3. [20] Let {X1,..., Xn} be a random sample from a binomial distribution Bin(30, p), where p (0, 1) is unknown. Let {x1,...,xn} be an observed sample. (a) Find the likelihood function of p. (b) Find the MLE, p, of p. (c) Find the bias and MSE of p.

Given the sample space: ΩΞ = {a,b,c,d,e,f} and events: {a,b,e,f} A = {a, b, c, d}, B = {c, d, e, f}, and C = {a, b, e, f} For parts a-c: determine the outcomes in each of the provided sets. Use proper set notation. a. (ACB) C (AN (BUC) C) U (AN (BUC)) AC UBC UCC b. C. d. If the outcomes in 2 are equally likely, calculate P(AN BNC).

Suppose a sample of O-rings was obtained and the wall thickness (in inches) of each was recorded. Use a normal probability plot to assess whether the sample data could have come from a population that is normally distributed. Click here to view the table of critical values for normal probability plots. Click here to view page 1 of the standard normal distribution table. Click here to view page 2 of the standard normal distribution table. 0.191 0.186 0.201 0.2005 0.203 0.210 0.234 0.248 0.260 0.273 0.281 0.290 0.305 0.310 0.308 0.311 Using the correlation coefficient of the normal probability plot, is it reasonable to conclude that the population is normally distributed? Select the correct choice below and fill in the answer boxes within your choice. (Round to three decimal places as needed.) ○ A. Yes. The correlation between the expected z-scores and the observed data, , exceeds the critical value, . Therefore, it is reasonable to conclude that the data come from a normal population. ○…

ding question ypothesis at a=0.01 and at a = 37. Consider the following hypotheses: 20 Ho: μ=12 HA: μ12 Find the p-value for this hypothesis test based on the following sample information. a. x=11; s= 3.2; n = 36 b. x = 13; s=3.2; n = 36 C. c. d. x = 11; s= 2.8; n=36 x = 11; s= 2.8; n = 49

13. A pharmaceutical company has developed a new drug for depression. There is a concern, however, that the drug also raises the blood pressure of its users. A researcher wants to conduct a test to validate this claim. Would the manager of the pharmaceutical company be more concerned about a Type I error or a Type II error? Explain.

Find the z score that corresponds to the given area 30% below z.

Find the following probability P(z<-.24)

3. Explain why the following statements are not correct. a. "With my methodological approach, I can reduce the Type I error with the given sample information without changing the Type II error." b. "I have already decided how much of the Type I error I am going to allow. A bigger sample will not change either the Type I or Type II error." C. "I can reduce the Type II error by making it difficult to reject the null hypothesis." d. "By making it easy to reject the null hypothesis, I am reducing the Type I error."

Given the following sample data values: 7, 12, 15, 9, 15, 13, 12, 10, 18,12 Find the following: a) Σ x= b) x² = c) x = n d) Median = e) Midrange x = (Enter a whole number) (Enter a whole number) (use one decimal place accuracy) (use one decimal place accuracy) (use one decimal place accuracy) f) the range= g) the variance, s² (Enter a whole number) f) Standard Deviation, s = (use one decimal place accuracy) Use the formula s² ·Σx² -(x)² n(n-1) nΣ x²-(x)² 2 Use the formula s = n(n-1) (use one decimal place accuracy)